Suppr超能文献

对从皮肤病标本中分离出的霉菌的体外抗真菌活性

In Vitro Antifungal Activities against Moulds Isolated from Dermatological Specimens.

作者信息

Mohd Nizam Tzar, Binting Rabiatul Adawiyah Ag, Mohd Saari Shafika, Kumar Thivyananthini Vijaya, Muhammad Marianayati, Satim Hartini, Yusoff Hamidah, Santhanam Jacinta

机构信息

Department of Medical Microbiology and Immunology, Universiti Kebangsaan Malaysia Medical Centre, Bandar Tun Razak, 56000 Kuala Lumpur, Malaysia.

Programme of Biomedical Science, School of Diagnostic and Applied Health Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia.

出版信息

Malays J Med Sci. 2016 May;23(3):32-9.

Abstract

BACKGROUND

This study aimed to determine the minimum inhibitory concentrations (MICs) of various antifungal agents against moulds isolated from dermatological specimens.

METHODS

We identified 29 moulds from dermatological specimens between October 2012 and March 2013 by conventional methods. We performed antifungal susceptibility testing on six antifungal agents, amphotericin B, clotrimazole, itraconazole, ketoconazole, miconazole and terbinafine, according to the Clinical and Laboratory Standards Institute guidelines contained in the M38-A2 document.

RESULTS

Most antifungal agents were active against the dermatophytes, except for terbinafine against Trichophyton rubrum (geometric mean MIC, MICGM 3.17 μg/mL). The dematiaceous moulds were relatively susceptible to amphotericin B and azoles (MICGM 0.17-0.34 μg/mL), but not to terbinafine (MICGM 3.62 μg/mL). Septate hyaline moulds showed variable results between the relatively more susceptible Aspergillus spp. (MICGM 0.25-4 μg/mL) and the more resistant Fusarium spp. (MICGM 5.66-32 μg/mL). The zygomycetes were susceptible to amphotericin B (MICGM 0.5 μg/mL) and clotrimazole (MICGM 0.08 μg/mL), but not to other azoles (MICGM 2.52-4 μg/mL).

CONCLUSION

Amphotericin B and clotrimazole were the most effective antifungal agents against all moulds excepting Fusarium spp., while terbinafine was useful against dermatophytes (except T. rubrum) and Aspergillus spp. However, a larger study is required to draw more solid conclusions.

摘要

背景

本研究旨在确定多种抗真菌药物对从皮肤病标本中分离出的霉菌的最低抑菌浓度(MIC)。

方法

我们采用常规方法在2012年10月至2013年3月期间从皮肤病标本中鉴定出29种霉菌。根据M38 - A2文件中包含的临床和实验室标准协会指南,我们对六种抗真菌药物进行了抗真菌药敏试验,这六种药物分别为两性霉素B、克霉唑、伊曲康唑、酮康唑、咪康唑和特比萘芬。

结果

除特比萘芬对红色毛癣菌外(几何平均MIC,MICGM 3.17μg/mL),大多数抗真菌药物对皮肤癣菌有活性。暗色霉菌对两性霉素B和唑类相对敏感(MICGM 0.17 - 0.34μg/mL),但对特比萘芬不敏感(MICGM 3.62μg/mL)。有隔透明霉菌在相对更敏感的曲霉属(MICGM 0.25 - 4μg/mL)和更耐药的镰刀菌属(MICGM 5.66 - 32μg/mL)之间表现出不同的结果。接合菌对两性霉素B(MICGM 0.5μg/mL)和克霉唑(MICGM 0.08μg/mL)敏感,但对其他唑类不敏感(MICGM 2.52 - 4μg/mL)。

结论

两性霉素B和克霉唑是除镰刀菌属外对所有霉菌最有效的抗真菌药物,而特比萘芬对皮肤癣菌(红色毛癣菌除外)和曲霉属有用。然而,需要进行更大规模的研究以得出更可靠的结论。

相似文献

2
In vitro susceptibility of seven antifungal agents against dermatophytes isolated in İstanbul.
Turk J Med Sci. 2018 Jun 14;48(3):615-619. doi: 10.3906/sag-1709-157.
3
In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Int J Dermatol. 2013 Dec;52(12):1557-60. doi: 10.1111/ijd.12100. Epub 2013 Oct 18.
7
Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates.
Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1841-1846. doi: 10.1007/s10096-018-3317-4. Epub 2018 Jul 7.
8
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Mycoses. 2022 Nov;65(11):981-988. doi: 10.1111/myc.13481. Epub 2022 Jun 30.
10
In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs.
J Mycol Med. 2015 Mar;25(1):44-9. doi: 10.1016/j.mycmed.2014.10.024. Epub 2014 Dec 22.

引用本文的文献

1
Atypical presentation for a gastrointestinal basidiobolomycosis and rare side effect of Voriconazole: A case report and literature review.
Med Mycol Case Rep. 2025 Jul 17;49:100719. doi: 10.1016/j.mmcr.2025.100719. eCollection 2025 Sep.
3
Experimental Phaeohyphomycosis of .
J Clin Med. 2022 Sep 14;11(18):5393. doi: 10.3390/jcm11185393.
5
A 23 bp Promoter Deletion Associated With Voriconazole Resistance in Clinical and Environmental Isolates of .
Front Microbiol. 2020 Mar 31;11:272. doi: 10.3389/fmicb.2020.00272. eCollection 2020.
6
Antifungal Drug Susceptibility Testing of Dermatophytes: Laboratory Findings to Clinical Implications.
Indian Dermatol Online J. 2019 May-Jun;10(3):225-233. doi: 10.4103/idoj.IDOJ_146_19.

本文引用的文献

1
What's new in the treatment and diagnosis of dermatophytosis?
Semin Cutan Med Surg. 2014 Sep;33(3):136-9. doi: 10.12788/j.sder.0110.
2
In vitro activities of eight antifungal drugs against 104 environmental and clinical isolates of Aureobasidium pullulans.
Antimicrob Agents Chemother. 2014 Sep;58(9):5629-31. doi: 10.1128/AAC.03095-14. Epub 2014 Jul 7.
3
Subcutaneous zygomycosis of the cervicotemporal region: Due to Basidiobolus ranaram.
Med Mycol Case Rep. 2012 Aug 4;1(1):59-62. doi: 10.1016/j.mmcr.2012.07.004. eCollection 2012.
5
In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Int J Dermatol. 2013 Dec;52(12):1557-60. doi: 10.1111/ijd.12100. Epub 2013 Oct 18.
6
Emergence of gastrointestinal basidiobolomycosis in the United States, with a review of worldwide cases.
Clin Infect Dis. 2012 Jun;54(12):1685-91. doi: 10.1093/cid/cis250. Epub 2012 Mar 22.
7
Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales.
J Clin Microbiol. 2012 Jan;50(1):66-75. doi: 10.1128/JCM.06133-11. Epub 2011 Nov 9.
9
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review.
Med Mycol. 2011 Nov;49(8):872-8. doi: 10.3109/13693786.2011.567304. Epub 2011 Mar 30.
10
Melanized fungi in human disease.
Clin Microbiol Rev. 2010 Oct;23(4):884-928. doi: 10.1128/CMR.00019-10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验